GlassScriptPhysician profile
Lauren Krolczyk
NPI 1528322070
$5,109.56
in general payments reported to CMS, 2019-2025
31 companies · $695 in 2025
The $695 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $298 · 2021: $573 · 2022: $1,082 · 2023: $1,202 · 2024: $860 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,757.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,011.88 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $689.45 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $539.50 | 2021-2025 | |
| Pfizer INC. | $351.84 | 2019-2025 | |
| Astellas Pharma US INC | $323.88 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $320.37 | 2021-2022 | |
| Biogen, INC. | $254.26 | 2024-2025 | Zurzuvae |
| Organon LLC | $233.57 | 2021-2025 | Nexplanon, Nuvaring |
| Aspira Women'S Health INC | $174.72 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $158.21 | 2019-2023 | Gardasil 9 |
| Hologic Sales and Service, LLC | $156.50 | 2022-2024 | Novasure, Coolseal Generator, Acessa Provu System |
| Exeltis, USA INC. | $153.21 | 2019-2025 | Slynd, Solosec |
| Therapeuticsmd, INC. | $121.38 | 2019-2022 | |
| Agile Therapeutics, INC. | $113.41 | 2021-2023 | Twirla |
| Lupin INC. | $86.54 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $67.30 | 2021-2025 | Paragard T 380a |
| Idorsia Pharmaceuticals US INC | $49.90 | 2023 | Quviviq |
| Daiichi Sankyo INC. | $47.54 | 2020-2021 | |
| Baxter Healthcare | $27.66 | 2021 | |
| Smith+Nephew, INC. | $26.54 | 2023 | Pico 7 |
| Olympus America INC. | $24.98 | 2024 | |
| Gynesonics, INC. | $23.23 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $22.80 | 2025 | Femlyv |
| Duchesnay USA Incorporated | $22.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.92 | 2023 | |
| Mission Pharmacal Company | $17.43 | 2020 | |
| Allergan, INC. | $16.63 | 2020 | |
| Shield Therapeutics INC | $14.89 | 2023 | Accrufer |
| Scynexis, INC. | $14.41 | 2022 | |
| Virtus Pharmaceuticals LLC | $13.36 | 2020 | |
| Amneal Pharmaceuticals LLC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Krolczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.